QIAGEN agrees to takeover at €46.50 per share from EQT-led bidder
QIAGEN agreed to a voluntary tender offer from EQT-led Crown NL Bidco at €46.50 per share. Closing is expected in mid-2027, subject to conditions.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
QIAGEN N.V. has entered an agreement with Crown NL Bidco, led by EQT, for a voluntary tender offer at €46.50 per share. According to the press release distributed by EQS, the deal values the company at about €10.8 billion on an enterprise value basis. The offer carries a 40.3% premium to the share price on July 8, 2026.
QIAGEN's preliminary third-quarter 2026 sales were $548 million, with adjusted diluted earnings per share of $0.65. The company suspended its full-year 2026 outlook. Closing is expected in mid-2027 and is subject to conditions, with a minimum acceptance threshold of 50% plus one share.
why it matters
With guidance suspended, the share price is now likely to track the odds of the deal closing rather than operating results. Key factors include tender uptake, regulatory approvals and any delays, which could widen the spread to the offer price.
market impact
QIAGEN shares: price anchored to deal terms, spread depends on closing odds
tags
instruments
sources
- QIAGEN N.V. (QIA) Agrees to €46.50/Share Takeover; Q3 Sales $548M, EPS $0.65 — eqs-news.com, 21 October 2026 at 21:32 UTC
- QIAGEN N.V. (QIA) Posts Preliminary Q3 Sales $548M, EPS $0.65 — TradingView, 21 October 2026 at 21:44 UTC
- QIAGEN N.V. (QIA) Agrees to €46.50/Share All-Cash Takeover by EQT — TradingView, 21 October 2026 at 21:43 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗